Red Orbit (Free subscription) | yesterday
SAN DIEGO, Dec. 2 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) will present at the 21st Annual Piper Jaffray Health Care Conference today at 2:30 p.m. Eastern Time.
PR News Wire (Free subscription) | 01/12/2009
LANSING, Mich., Dec. 1 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) announced today that it has acquired the BioKits food safety business of San Diego, Calif.-based Gen-Probe Incorporated (Nasdaq: GPRO). The acquisition includes more than 50 test kits for food allergens, meat and fish speciation, and plant genetics.
Red Orbit (Free subscription) | 01/12/2009
LANSING, Mich., Dec. 1 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) announced today that it has acquired the BioKits food safety business of San Diego, Calif.-based Gen-Probe Incorporated (Nasdaq: GPRO).
San Diego Union (Free subscription) | 30/11/2009
Carl W. Hull took over in May as chief executive of Gen-Probe, one of the largest of San Diego County’s hundreds of biomedical businesses.
MassDevice - Medical device news, information and jobs... (Free subscription) | 28/11/2009
Gen-Probe suit says Becton, Dickinson's Viper system infringes on blood- and fluid-screening technology supporting much of its diagnostics business Gen-Probe Inc. wants to put Becton, Dickinson & Co. to the acid test. Specifically, probing how BD tests nucleic acid to spot viruses. The San Diego-based diagnostics company recently filed suit accusing its New Jersey-based rival of undermining several...
SeekingAlpha.com (Free subscription) | 26/11/2009
Zacks.com submits: Recently, Gen-Probe Inc. ( GPRO ) announced that it has received the green light from the U.S. Food and Drug Administration (FDA) to market ProParaflu Plus assay. The assay, developed by Prodesse, a wholly-owned subsidiary of Gen-Probe, is a molecular test for detecting and differentiating parainfluenza 1, 2, and 3 viruses that cause lower respiratory tract infections. The assay...
PR News Wire (Free subscription) | 24/11/2009
SAN DIEGO, Nov. 24 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the US Food and Drug Administration (FDA) has cleared for marketing Prodesse's ProParaflu+(TM) assay, a molecular test that detects and differentiates parainfluenza 1, 2 and 3 viruses, which cause lower respiratory tract infections.
PR News Wire (Free subscription) | 16/11/2009
SAN DIEGO, Nov. 16 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will webcast its annual meeting with institutional investors and financial analysts in New York on Thursday, December 3, 2009, at 9 a.m. Eastern Time (ET). The event will feature presentations on Gen-Probe's current business and future growth strategies by several Company executives....
San Diego Union (Free subscription) | 30/10/2009
Gen-Probe said it received emergency authorization to market a test for H1N1 “swine” flu virus infection. The San Diego company said the clearance from the Food and Drug Administration for its Prodesse ProFlu-ST is only good for the duration of the public health emergency, currently defined by the FDA as running through April 26.
SeekingAlpha.com (Free subscription) | 30/10/2009
Gen-probe, Inc. ( GPRO) Q3 2009 Earnings Call October 29, 2009 4:30 AM ET Complete Story »
PR News Wire (Free subscription) | 29/10/2009
SAN DIEGO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) today reported financial results for the third quarter of 2009, with record product sales and total revenues driving non-GAAP earnings per share (EPS) of $0.47.
Rocky Mount Telegram - Business (Free subscription) | 29/10/2009
SAN DIEGO — Gen-Probe Inc. said Thursday the Food and Drug Administration granted emergency ap...
Seattle Times (Free subscription) | 29/10/2009
Gen-Probe Inc. said Thursday the Food and Drug Administration granted emergency approval to its diagnostic test for the 2009 swine flu.
Star Tribune (Free subscription) | 29/10/2009
The test maker said the FDA approved its Prodesse ProFlu-ST test, which Gen-Probe says can diagnose swine flu in as little as three hours, while tests using throat cultures can take weeks.
San Fransisco Chronicle (Free subscription) | 29/10/2009
Gen-Probe Inc. said Thursday the Food and Drug Administration granted emergency approval to its diagnostic test for the 2009 swine flu. The test maker said the FDA approved its Prodesse ProFlu-ST test, which Gen-Probe says can diagnose swine flu in as little... Sponsored Topics: Food and Drug Administration - Swine influenza - United States - Health - Infectious disease
Videos